-
Bayer To Cut 12,000 Jobs Following Monsanto Purchase
Monday, December 3, 2018 - 12:01pm | 417Read More...Earlier this year, German pharmaceutical company Bayer AG (OTC: BAYRY) announced its $60-million acquisition of Monsanto. The agrochemical company recently faced litigation tied to its weedkiller RoundUp. What Happened Bayer will cut roughly 12,000 jobs globally by the end...
-
Jefferies Downgrades AstraZeneca, Sees Limited Additional Upside
Thursday, August 16, 2018 - 11:05am | 402Read More...The best kind of analyst downgrade for investors is the one that comes because a stock has performed so well that it has exceeded expectations. On Thursday, AstraZeneca plc (ADR) (NYSE: AZN) was hit with just such a downgrade. The Analyst Jefferies analyst Ian Hilliker downgraded AstraZeneca from...
-
Jefferies Shares Pharma Stock Catalyst Outlook
Tuesday, June 14, 2016 - 4:33pm | 917Read More...Jefferies analysts led by Jeffrey Holford and Ian Hilliker shared their monthly update on the global pharmaceuticals industry. The firm sees attractive catalysts in the sector, and believe fundamentals and valuation are alluring. However, “investors may need a little more patience whilst we...
-
Jefferies Raises Pfizer PT, Says Company Has Multiple Ways To Win
Monday, March 23, 2015 - 9:36am | 180Read More...Jefferies on Monday issued a report on Pfizer Inc. (NYSE: PFE), raising its price target from $42 to $45. Jefferies rates Pfizer as a Buy. Analysts Jeffrey Holland, David Gu, Ian Hilliker and Sissi Qiong Hai wrote, "We expect Pfizer shares to significantly appreciate over the next 1-2 years based...
